dennis.p
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

dennis.p

Forum Replies Created

Viewing 0 reply threads
  • Replies
      • June 1, 2018 at 2:19 pm
      dennis.p
      Participant

      Hi RedRobyn,

      My dad has been on Keytruda for 6 months now (today he had his 9th infusion). The doctors say that for melanoma it is kinda lifelong treatment… Indeed if you see the leaflet https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125514s012lbl.pdf – please compare pts. 2.2, 2.3 and 2.4 – they say to stop keytruda for lung/head&neck cancers after 24 months in case of no progression, but nothing for melanoma… 

      This was a rather disappointing news (as the drug is prohibitively expensive), but it would be very interesting to hear what others' doctors say in other parts of the world (we are located in Ukraine).

      Stay healthy 🙂

       

       

       

       

Viewing 0 reply threads
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.